1-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine → HCID 66616474, 화합물

HRID 1914227

반응식

HRID 1914227 반응식
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:11]2[C:12]([CH2:19][CH3:20])([CH2:17][CH3:18])[C:13](=[O:16])[NH:14][N:15]=2)[CH:6]=[CH:7][C:8]=1[O:9][CH3:10].CC1C=CC(S(O[CH:32]2[CH2:37][CH2:36][N:35](C(OC(C)(C)C)=O)[CH2:34][CH2:33]2)(=O)=O)=CC=1>>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:11]2[C:12]([CH2:19][CH3:20])([CH2:17][CH3:18])[C:13](=[O:16])[N:14]([CH:32]3[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]3)[N:15]=2)[CH:6]=[CH:7][C:8]=1[O:9][CH3:10]

참가 물질

3

반응물 2

HCID 157347131-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine2회HCID 666166225-(3,4-dimethoxyphenyl)-4,4-diethyl-2,4-dihydro-3H-pyrazol-3-one2회

생성물 1

HCID 66616474HCID 66616474, 화합물

실험 절차

Prepared analogously as described for the example B1 (Alternative 1) using 5-(3,4-dimethoxyphenyl)-4,4-diethyl-2,4-dihydro-3H-pyrazol-3-one (compound C7) and tert-butyl 4-(Toluene-4-sulfonyloxy)piperidine-1-carboxylate (compound E1) as starting compounds resulting in the title compound. (compound B7)

후처리

  1. customPrepared analogously

출처 및 근거

ORD 기록
ord-a7bfe601f7184030a696ae6109da24a0
출처 데이터셋
uspto-grants-2013_12
특허 번호
US08609848B2

연결된 노트

불러오는 중…